Novo Nordisk Files Routine 6-K Report
Ticker: NVO · Form: 6-K · Filed: Apr 20, 2026 · CIK: 0000353278
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer
TL;DR
Novo Nordisk dropped a 6-K filing on 4/20/26, looks like routine paperwork.
AI Summary
Novo Nordisk A/S filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself and associated graphics, with no specific financial transactions or material events detailed in the provided text.
Why It Matters
This filing indicates standard regulatory reporting by Novo Nordisk as a foreign issuer, providing transparency to investors about ongoing corporate activities.
Risk Assessment
Risk Level: low — The filing is a standard foreign issuer report (6-K) and does not contain information about significant financial events, acquisitions, or operational changes.
Key Players & Entities
- NOVO NORDISK A S (company) — Filer
- 0000353278 (company) — CIK Number for NOVO NORDISK A S
- 2026-04-20 (date) — Filing Date and Period of Report
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to furnish information which the issuer makes or is required to make public pursuant to the laws of its home country.
When was this specific Form 6-K filed by Novo Nordisk?
This Form 6-K was filed on April 20, 2026.
What is Novo Nordisk's CIK number?
Novo Nordisk's CIK number is 0000353278.
What is the business address of Novo Nordisk as listed in the filing?
The business address listed is NOVO ALLE DK 2880 BAGSVAERD DENMARK.
Does this filing indicate any specific new financial transactions or material events?
Based on the provided text, this filing appears to be a routine report and does not detail specific new financial transactions or material events.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 20, 2026 regarding NOVO NORDISK A S (NVO).